Anthony G. Comuzzie

Anthony G. Comuzzie

Auto-generated profile, based on publicly available information

Anthony G. Comuzzie

Auxology and Metabolism Working Group, Department of Genetics, Southwest Foundation for Biomedical Research, San Antonio, TX, USA.

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1999 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
JHJames E. Hixson
James E. Hixson
LALaura Almasy
Laura Almasy
SCShelley Cole
Shelley Cole
SBShifra Birnbaum
Shifra Birnbaum
BMBraxton Mitchell
Braxton Mitchell
ACAnthony G. Comuzzie
Anthony G. Comuzzie
We previously reported that our genome-scanning initiative had detected a highly significant linkage (log odds ratio = 4.95; P = 9 x 10(-7)) between a quantitative trait locus (QTL) on chromosome 2 and leptin levels in Mexican American families. We now have typed additional microsatellite markers in this region, increasing this log odds ratio score to 7.46 (P = 2 x 10(-9)). This region of chromosome 2 contains a strong positional candidate gene, POMC. The POMC gene codes for POMC, the prohormone from which alphaMSH, ACTH, and beta-endorphin are derived. Studies by others have shown that POMC-derived products are involved in the regulation of appetite and obesity. We have used polymorphisms in POMC to map its location within the 95% confidence interval of the peak for the linkage signal for the QTL. We also constructed POMC haplotypes using these polymorphisms and have found a significant association with normal variation in leptin levels (P = 0.001). We conclude that variation in POMC is associated with normal variation in serum leptin levels, providing further evidence that POMC may be the leptin QTL previously identified in Mexican American families.

10 January 2002 in Genetic Epidemiology
Verified
Journal Article
Closed access
PDF file
LMLisa Martin
Lisa Martin
SCShelley Cole
Shelley Cole
JHJames E. Hixson
James E. Hixson
MMMichael C. Mahaney
Michael C. Mahaney
SCStefan A. Czerwinski
Stefan A. Czerwinski
ACAnthony G. Comuzzie
Anthony G. Comuzzie

1 January 2007 in Human Biology
Verified
Journal Article
Closed access
PDF file
ACAnthony G. Comuzzie
Anthony G. Comuzzie
MTM. Elizabeth. Tejero
M. Elizabeth. Tejero
TFTohru. Funahashi
Tohru. Funahashi
LMLisa Martin
Lisa Martin
AKAhmed. Kissebah
Ahmed. Kissebah
JBJohn. Balangero
John. Balangero
Results from previous studies suggest that adiponectin levels are associated with risk factors for cardiovascular disease and type 2 diabetes mellitus; however, the genetic and/or environmental components of this relationship have not been characterized. The aims of this study were (1) to assess the presence of pleiotropy between adiponectin levels and risk factors for cardiovascular disease and (2) to study the association of circulating levels of adiponectin with risk factors for cardiovascular disease in the absence and presence of obesity in Mexican American adults from the San Antonio Family Heart Study. Body composition and circulating levels of adiponectin, leptin, and lipid subfractions and measurements of glucose metabolism were measured in 898 subjects. The mean and standard error of the circulating levels of adiponectin was 8.7 ± 3.2 μg/ml. Bivariate quantitative analyses between adiponectin levels and phenotypes related to cardiovascular disease and type 2 diabetes mellitus were conducted using the variance decomposition approach implemented in SOLAR. A second analysis in unrelated subjects compared these risk factors between sex- and age-matched lean and obese subjects with high and low adiponectin levels. We found significant evidence of pleiotropy (i.e., shared genetic effects) between plasma levels of adiponectin and well-established risk factors for cardiovascular disease and type 2 diabetes mellitus. Individuals with low adiponectin levels per body weight had more adverse risk profiles. These findings offer new insights into the genetic connection between increasing adiposity and risk for cardiovascular disease and type 2 diabetes mellitus, and they suggest that adiponectin may be an important risk factor for the development of these conditions.

12 June 2015 in Biological Research
Verified
Journal Article
Open access
PDF file
RGRafael González-Alvarez
Rafael González-Alvarez
Maria Lourdes Garza-RodríguezMaria Lourdes Garza-Rodríguez
Maria Lourdes Garza-Rodríguez
Ivan Delgado-EncisoIvan Delgado-Enciso
Ivan Delgado-Enciso
VICTOR TREVINOVICTOR TREVINO
VICTOR TREVINO
RCRicardo Canales-Del-Castillo
Ricardo Canales-Del-Castillo
IRIram Pablo Rodriguez-Sanchez
Iram Pablo Rodriguez-Sanchez
Chemerin, encoded by the retinoic acid receptor responder 2 (RARRES2) gene is an adipocytesecreted protein with autocrine/paracrine functions in adipose tissue, metabolism and inflammation with a recently described function in vascular tone regulation, liver, steatosis, etc. This molecule is believed to represent a critical endocrine signal linking obesity to diabetes. There are no data available regarding evolution of RARRES2 in non-human primates and great apes. Expression profile and orthology in RARRES2 genes are unknown aspects in the biology of this multigene family in primates. Thus; we attempt to describe expression profile and phylogenetic relationship as complementary knowledge in the function of this gene in primates. To do that, we performed A RT-PCR from different tissues obtained during necropsies. Also we tested the hypotheses of positive evolution, purifying selection, and neutrality. And finally a phylogenetic analysis was made between primates RARRES2 protein. RARRES2 transcripts were present in liver, lung, adipose tissue, ovary, pancreas, heart, hypothalamus and pituitary tissues. Expression in kidney and leukocytes were not detectable in either species. It was determined that the studied genes are orthologous. RARRES2 evolution fits the hypothesis of purifying selection. Expression profiles of the RARRES2 gene are similar in baboons and chimpanzees and are also phylogenetically related.

1 December 2007 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
GCGuowen Cai
Guowen Cai
SCShelley A. Cole
Shelley A. Cole
NBNancy F. Butte
Nancy F. Butte
VVV. Saroja Voruganti
V. Saroja Voruganti
ACAnthony G. Comuzzie
Anthony G. Comuzzie
Objective: The prevalence of childhood obesity has increased dramatically in the United States. Early presentation of type 2 diabetes has been observed in children and adolescents, especially in the Hispanic population. The genetic contribution of glucose homeostasis related to childhood obesity is poorly understood. The objective of this study was to localize quantitative trait loci influencing fasting serum glucose levels in Hispanic children participating in the Viva La Familia Study. Design: Subjects were 1030 children ascertained through an overweight child from 319 Hispanic families. Fasting serum glucose levels were measured enzymatically, and genetic linkage analyses were conducted using SOLAR software. Results: Fasting glucose was heritable, with a heritability of 0.62 ± 0.08 (P < 0.01). Genome-wide scan mapped fasting serum glucose to markers D13S158–D13S173 on chromosome 13q (LOD score of 4.6). A strong positional candidate gene is insulin receptor substrate 2, regulator of glucose homeostasis and a candidate gene for obesity. This region was reported previously to be linked to obesity- and diabetes-related phenotypes. Conclusions: A quantitative trait locus on chromosome 13q contributes to the variation in fasting serum glucose levels in Hispanic children at high risk for obesity.

31 December 2008
Verified
Journal Article
Closed access
RBRaul Bastarrachea
Raul Bastarrachea
JLJuan Carlos López-Alvarenga
Juan Carlos López-Alvarenga
JKJack W Kent
Jack W Kent
HLHugo A Laviada-Molina
Hugo A Laviada-Molina
RCRicardo Cerda-Flores
Ricardo Cerda-Flores
ACAnthony G Comuzzie
Anthony G Comuzzie